{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:24:45Z","timestamp":1791224685847,"version":"4.1.0"},"reference-count":312,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Science and Technology Fund for Improvement of S&amp;T Infrastructure in Higher Educational Institutions (DST-FIST)","award":["SR\/FST\/LS-II\/2019\/615"],"award-info":[{"award-number":["SR\/FST\/LS-II\/2019\/615"]}]},{"name":"Departments Information Technology, Biotechnology and Science and Technology, Government of Karnataka, India","award":["SR\/FST\/LS-II\/2019\/615"],"award-info":[{"award-number":["SR\/FST\/LS-II\/2019\/615"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Multiple myeloma (MM) is a dyscrasia of plasma cells (PCs) characterized by abnormal immunoglobulin (Ig) production. The disease remains incurable due to a multitude of mutations and structural abnormalities in MM cells, coupled with a favorable microenvironment and immune suppression that eventually contribute to the development of drug resistance. The bone marrow microenvironment (BMME) is composed of a cellular component comprising stromal cells, endothelial cells, osteoclasts, osteoblasts, and immune cells, and a non-cellular component made of the extracellular matrix (ECM) and the liquid milieu, which contains cytokines, growth factors, and chemokines. The bone marrow stromal cells (BMSCs) are involved in the adhesion of MM cells, promote the growth, proliferation, invasion, and drug resistance of MM cells, and are also crucial in angiogenesis and the formation of lytic bone lesions. Classical immunophenotyping in combination with advanced immune profiling using single-cell sequencing technologies has enabled immune cell-specific gene expression analysis in MM to further elucidate the roles of specific immune cell fractions from peripheral blood and bone marrow (BM) in myelomagenesis and progression, immune evasion and exhaustion mechanisms, and development of drug resistance and relapse. The review describes the role of BMME components in MM development and ongoing clinical trials using immunotherapeutic approaches.<\/jats:p>","DOI":"10.3390\/biom13111629","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T11:23:39Z","timestamp":1699356219000},"page":"1629","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Good Cop, Bad Cop: Profiling the Immune Landscape in Multiple Myeloma"],"prefix":"10.3390","volume":"13","author":[{"given":"Niyati Seshagiri","family":"Sharma","sequence":"first","affiliation":[{"name":"Institute of Bioinformatics and Applied Biotechnology (IBAB), Electronic City, Bengaluru 560100, India"},{"name":"Manipal Academy of Higher Education (MAHE), Manipal 576104, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibha","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics and Applied Biotechnology (IBAB), Electronic City, Bengaluru 560100, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Rieger, M.A., and Schroeder, T. (2012). Hematopoiesis. Cold Spring Harb. Perspect. Biol., 4.","DOI":"10.1101\/cshperspect.a008250"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Elsaid, R., Soares-Da-Silva, F., Peixoto, M., Amiri, D., Mackowski, N., Pereira, P., Bandeira, A., and Cumano, A. (2020). Hematopoiesis: A Layered Organization Across Chordate Species. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.606642"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1182\/blood-2007-02-069625","article-title":"Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma","volume":"110","author":"Fenton","year":"2007","journal-title":"Blood"},{"key":"ref_4","unstructured":"Godin, I., and Cumano, A. (2010). Hematopoietic Stem Cell Development, Springer Science & Business Media."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3389\/fimmu.2019.01121","article-title":"Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma","volume":"10","author":"Barwick","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and Management of Multiple Myeloma: A Review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/s41467-020-15740-9","article-title":"Timing the initiation of multiple myeloma","volume":"11","author":"Rustad","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Padala, S.A., Barsouk, A., Barsouk, A., Rawla, P., Vakiti, A., Kolhe, R., Kota, V., and Ajebo, G.H. (2021). Epidemiology, Staging, and Management of Multiple Myeloma. Med. Sci., 9.","DOI":"10.3390\/medsci9010003"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(14)60493-1","article-title":"Multiple myeloma","volume":"385","author":"Knop","year":"2015","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zhou, L., Yu, Q., Wei, G., Wang, L., Huang, Y., Hu, K., Hu, Y., and Huang, H. (2021). Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08280-y"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ejh.13083","article-title":"Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival","volume":"101","author":"Turesson","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: A unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin. Oncol."},{"key":"ref_15","unstructured":"International Myeloma Foundation (2022, October 08). Durie-Salmon Staging System. Available online: https:\/\/www.myeloma.org\/."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2214\/AJR.16.17219","article-title":"A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?","volume":"209","author":"Filonzi","year":"2017","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_17","unstructured":"International Myeloma Foundation (2022, October 08). International Staging System (ISS) and Revised ISS (R-ISS). Available online: https:\/\/www.myeloma.org\/."},{"key":"ref_18","unstructured":"International Myeloma Foundation (2022, October 08). International Myeloma Working Group (IMWG) criteria for the diagnosis of multiple myeloma. Available online: https:\/\/www.myeloma.org\/."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cancergencyto.2010.11.002","article-title":"The prognostic significance of cytogenetics and molecular profiling in multiple myeloma","volume":"204","author":"Sawyer","year":"2011","journal-title":"Cancer Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2141.2003.04417.x","article-title":"Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma","volume":"122","author":"Liebisch","year":"2003","journal-title":"Br. J. Haematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.ejca.2006.04.005","article-title":"Genetics and molecular profiling of multiple myeloma: Novel tools for clinical management?","volume":"42","author":"Tassone","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1200\/JCO.2005.05.021","article-title":"Molecular Pathogenesis and a Consequent Classification of Multiple Myeloma","volume":"23","author":"Bergsagel","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrc2189","article-title":"Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets","volume":"7","author":"Hideshima","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nyas.13038","article-title":"Multiple myeloma in the marrow: Pathogenesis and treatments","volume":"1364","author":"Fairfield","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc746","article-title":"Multiple myeloma: Evolving genetic events and host interactions","volume":"2","author":"Kuehl","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1038\/sj.onc.1204641","article-title":"Chromosome translocations in multiple myeloma","volume":"20","author":"Bergsagel","year":"2001","journal-title":"Oncogene"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1038\/bcj.2015.92","article-title":"Interpretation of cytogenetic results in multiple myeloma for clinical practice","volume":"5","author":"Rajan","year":"2015","journal-title":"Blood Cancer J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-3-540-85772-3_6","article-title":"Monoclonal gammopathy and smoldering multiple myeloma: Diagnosis, staging, prognosis, management","volume":"183","author":"Hillengass","year":"2011","journal-title":"Recent Results Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1182\/blood-2011-01-270140","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): Novel biological insights and development of early treatment strategies","volume":"117","author":"Korde","year":"2011","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2141.1998.00657.x","article-title":"Prognostic value of cytogenetics in multiple myeloma","volume":"101","author":"Seong","year":"1998","journal-title":"Br. J. Haematol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1182\/blood-2011-11-390658","article-title":"Trisomies in multiple myeloma: Impact on survival in patients with high-risk cytogenetics","volume":"119","author":"Kumar","year":"2012","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2016-01-631200","article-title":"Treatment of multiple myeloma with high-risk cytogenetics: A consensus of the International Myeloma Working Group","volume":"127","author":"Sonneveld","year":"2016","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/bjh.12223","article-title":"Cytogenetics of extramedullary manifestations in multiple myeloma","volume":"161","author":"Billecke","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ejh.12688","article-title":"Cytogenetics in multiple myeloma patients progressing into extramedullary disease","volume":"97","author":"Besse","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/bjh.17499","article-title":"Subgroup analysis of ICARIA-MM study in relapsed\/refractory multiple myeloma patients with high-risk cytogenetics","volume":"194","author":"Harrison","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/leu.2010.175","article-title":"Treatment of patients with relapsed\/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: Prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies","volume":"24","author":"Dimopoulos","year":"2010","journal-title":"Leukemia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41375-019-0660-0","article-title":"Extramedullary multiple myeloma","volume":"34","author":"Bhutani","year":"2019","journal-title":"Leukemia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1158\/1078-0432.CCR-10-1805","article-title":"Treatment Options for Relapsed and Refractory Multiple Myeloma","volume":"17","author":"Lonial","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.blre.2017.03.004","article-title":"The bone marrow microenvironment\u2014Home of the leukemic blasts","volume":"31","author":"Shafat","year":"2017","journal-title":"Blood Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MOH.0000000000000265","article-title":"Heterogeneity of the bone marrow niche","volume":"23","author":"Yu","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological malignancies","volume":"20","author":"Bonnet","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","article-title":"Hematopoiesis: An Evolving Paradigm for Stem Cell Biology","volume":"132","author":"Orkin","year":"2008","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1242\/dev.083147","article-title":"Hematopoiesis","volume":"140","author":"Zon","year":"2013","journal-title":"Development"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-cellbio-020520-114601","article-title":"The Source and Dynamics of Adult Hematopoiesis: Insights from Lineage Tracing","volume":"36","author":"Pucella","year":"2020","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood.V91.9.3263","article-title":"Growth-supporting activities of fibronectin on hematopoietic stem\/progenitor cells in vitro and in vivo: Structural requirement for fibronectin activities of CS1 and cell-binding domains","volume":"91","author":"Yokota","year":"1998","journal-title":"Blood"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/107327480301000103","article-title":"Hematopoietic Stem Cells and Hematopoiesis","volume":"10","author":"Smith","year":"2003","journal-title":"Cancer Control."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.coi.2009.05.002","article-title":"Effects of aging on hematopoietic stem and progenitor cells","volume":"21","author":"Waterstrat","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"705410","DOI":"10.3389\/fcell.2021.705410","article-title":"The Hematopoietic Bone Marrow Niche Ecosystem","volume":"9","author":"Landspersky","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3324\/haematol.2014.113852","article-title":"A hostel for the hostile: The bone marrow niche in hematologic neoplasms","volume":"100","author":"Krause","year":"2015","journal-title":"Haematologica"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"jcs201707","DOI":"10.1242\/jcs.201707","article-title":"The bone marrow microenvironment in health and disease at a glance","volume":"131","author":"Kumar","year":"2018","journal-title":"J. Cell Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood-2017-12-784132","article-title":"The interplay of leukemia cells and the bone marrow microenvironment","volume":"131","author":"Duarte","year":"2018","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exphem.2020.07.010","article-title":"\u201cCaught in the net\u201d: The extracellular matrix of the bone marrow in normal hematopoiesis and leukemia","volume":"89","author":"Zanetti","year":"2020","journal-title":"Exp. Hematol."},{"key":"ref_54","first-page":"114069","article-title":"The extracellular matrix of hematopoietic stem cell niches","volume":"181","author":"Schertl","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/BF01921741","article-title":"The extracellular matrix of the hematopoietic microenvironment","volume":"51","author":"Klein","year":"1995","journal-title":"Experientia"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s40778-020-00172-4","article-title":"Mechanoregulation in Hematopoiesis and Hematologic Disorders","volume":"6","author":"Horton","year":"2020","journal-title":"Curr. Stem Cell Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/10245332.2018.1486064","article-title":"Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia","volume":"23","author":"Wang","year":"2018","journal-title":"Hematology"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Wirth, F., Lubosch, A., Hamelmann, S., and Nakchbandi, I.A. (2020). Fibronectin and Its Receptors in Hematopoiesis. Cells, 9.","DOI":"10.3390\/cells9122717"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood.V73.1.111.111","article-title":"Dual role of fibronectin in hematopoietic differentiation","volume":"73","author":"Weinstein","year":"1989","journal-title":"Blood"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10719-017-9773-8","article-title":"Heparan sulfate proteoglycans as key regulators of the mesenchymal niche of hematopoietic stem cells","volume":"34","author":"Albanese","year":"2017","journal-title":"Glycoconj. J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/sj.leu.2402738","article-title":"Proteoglycans on bone marrow endothelial cells bind and present SDF-1 towards hematopoietic progenitor cells","volume":"17","author":"Netelenbos","year":"2003","journal-title":"Leukemia"},{"key":"ref_62","first-page":"766","article-title":"Hierarchical organization of hematopoietic microenvironments: Role of proteoglycans","volume":"2","author":"Keating","year":"1988","journal-title":"Leukemia"},{"key":"ref_63","first-page":"18","article-title":"The role of glycosaminoglycans and proteoglycans in hemopoiesis and the physiological functions of the blood cells","volume":"82","author":"Kharchenko","year":"1996","journal-title":"Fiziol. Zhurnal Im. IM"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"756231","DOI":"10.3389\/fimmu.2021.756231","article-title":"Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia","volume":"12","author":"Grenier","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_65","unstructured":"Cambi, A., van Helden, S.F.G., and Figdor, C.G. (2013). Madame Curie Bioscience Database, Landes Bioscience."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1196\/annals.1349.008","article-title":"Involvement of proteases in cytokine-induced hematopoietic stem cell mobilization","volume":"1044","author":"Velders","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/jcb.21043","article-title":"Cytokines and hematopoietic stem cell mobilization","volume":"99","author":"Nervi","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1038\/leu.2017.102","article-title":"Proteomic characterization of human multiple myeloma bone marrow extracellular matrix","volume":"31","author":"Glavey","year":"2017","journal-title":"Leukemia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1369\/jhc.2008.952200","article-title":"Altered Expression of Fibronectin and Collagens I and IV in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance","volume":"57","author":"Tancred","year":"2008","journal-title":"J. Histochem. Cytochem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ajh.23409","article-title":"The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms","volume":"88","author":"Tadmor","year":"2013","journal-title":"Am. J. Hematol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s00018-006-6149-9","article-title":"Lysyl oxidase: An oxidative enzyme and effector of cell function","volume":"63","author":"Lucero","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.V93.9.3064.409k07_3064_3073","article-title":"Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma","volume":"93","author":"Vacca","year":"1999","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1182\/blood.V90.4.1649","article-title":"Metalloproteinases in Multiple Myeloma: Production of Matrix Metalloproteinase-9 (MMP-9), Activation of proMMP-2, and Induction of MMP-1 by Myeloma Cells","volume":"90","author":"Akhoundi","year":"1997","journal-title":"Blood"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fonc.2013.00327","article-title":"Serglycin: At the Crossroad of Inflammation and Malignancy","volume":"3","author":"Korpetinou","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"100787","DOI":"10.1016\/j.blre.2020.100787","article-title":"The extracellular matrix: A key player in the pathogenesis of hematologic malignancies","volume":"48","author":"Sidhu","year":"2020","journal-title":"Blood Rev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature17624","article-title":"Distinct bone marrow blood vessels differentially regulate haematopoiesis","volume":"532","author":"Itkin","year":"2016","journal-title":"Nature"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev-cellbio-111315-124936","article-title":"Regulation of Hematopoiesis and Osteogenesis by Blood Vessel\u2013Derived Signals","volume":"32","author":"Ramasamy","year":"2016","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/blood-2012-08-451864","article-title":"Perivascular support of human hematopoietic stem\/progenitor cells","volume":"121","author":"Corselli","year":"2013","journal-title":"Blood"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00109-017-1559-8","article-title":"Blood on the tracks: Hematopoietic stem cell-endothelial cell interactions in homing and engraftment","volume":"95","author":"Perlin","year":"2017","journal-title":"J. Mol. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.devcel.2021.05.018","article-title":"Niches that regulate stem cells and hematopoiesis in adult bone marrow","volume":"56","author":"Comazzetto","year":"2021","journal-title":"Dev. Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"Michurina","year":"2010","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13287-015-0266-z","article-title":"CD146\/MCAM defines functionality of human bone marrow stromal stem cell populations","volume":"7","author":"Harkness","year":"2016","journal-title":"Stem Cell Res Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature12612","article-title":"Arteriolar niches maintain haematopoietic stem cell quiescence","volume":"502","author":"Kunisaki","year":"2013","journal-title":"Nature"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1182\/blood-2004-09-3417","article-title":"VCAM-1 expression in adult hematopoietic and nonhematopoietic cells is controlled by tissue-inductive signals and reflects their developmental origin","volume":"106","author":"Ulyanova","year":"2005","journal-title":"Blood"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1182\/blood-2004-03-0989","article-title":"PECAM-1 is expressed on hematopoietic stem cells throughout ontogeny and identifies a population of erythroid progenitors","volume":"104","author":"Baumann","year":"2004","journal-title":"Blood"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.scr.2009.08.001","article-title":"Endothelial cells mediate the regeneration of hematopoietic stem cells","volume":"4","author":"Li","year":"2010","journal-title":"Stem Cell Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1006\/cyto.1999.0678","article-title":"Positive and negative hematopoietic cytokines produced by bone marrow endothelial cells","volume":"12","author":"Li","year":"2000","journal-title":"Cytokine"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0041-1345(97)00205-4","article-title":"Soluble factor(s) alone produced by primary porcine microvascular endothelial cells support the proliferation and differentiation of human CD34+ hematopoietic progenitor cells with a high replating potential","volume":"29","author":"Davis","year":"1997","journal-title":"Transpl. Proc."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nm973","article-title":"Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis","volume":"10","author":"Avecilla","year":"2003","journal-title":"Nat. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1182\/blood-2004-11-4269","article-title":"Tie2 activation contributes to hemangiogenic regeneration after myelosuppression","volume":"106","author":"Kopp","year":"2005","journal-title":"Blood"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jcp.1040910303","article-title":"Conditions controlling the proliferation of haemopoietic stem cells in vitro","volume":"91","author":"Dexter","year":"1977","journal-title":"J. Cell. Physiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.immuni.2016.11.004","article-title":"Hematopoietic Stem Cell Niches Produce Lineage-Instructive Signals to Control Multipotent Progenitor Differentiation","volume":"45","author":"Hara","year":"2016","journal-title":"Immunity"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Ria, R., and Vacca, A. (2020). Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020613"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Hideshima, T., and Anderson, K.C. (2021). Signaling Pathway Mediating Myeloma Cell Growth and Survival. Cancers, 13.","DOI":"10.3390\/cancers13020216"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"IJH39","DOI":"10.2217\/ijh-2021-0017","article-title":"Adhesion molecules in multiple myeloma oncogenesis and targeted therapy","volume":"11","author":"Nasr","year":"2022","journal-title":"Int. J. Hematol. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000203663","article-title":"The role of adhesion molecules in multiple myeloma","volume":"97","author":"Cook","year":"1997","journal-title":"Acta Haematol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ajh.2830500103","article-title":"Bone marrow of patients with active multiple myeloma: Angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44","volume":"50","author":"Vacca","year":"1995","journal-title":"Am. J. Hematol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2006-07-035857","article-title":"Mechanisms of regulation of CXCR4\/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma","volume":"109","author":"Alsayed","year":"2007","journal-title":"Blood"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.gene.2017.10.015","article-title":"The role of CXCL12 in tumor microenvironment","volume":"641","author":"Meng","year":"2018","journal-title":"Gene"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10456-017-9571-8","article-title":"Endothelial progenitor cells in multiple myeloma neovascularization: A brick to the wall","volume":"20","author":"Tenreiro","year":"2017","journal-title":"Angiogenesis"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/sj.leu.2403084","article-title":"Expression of VEGF and its receptors by myeloma cells","volume":"17","author":"Kumar","year":"2003","journal-title":"Leukemia"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Valkovi\u0107, T., Babarovi\u0107, E., Lu\u010din, K., \u0160tifter, S., Aralica, M., Pe\u0107ani\u0107, S., Seili-Bekafigo, I., Duleti\u0107-Na\u010dinovi\u0107, A., Nemet, D., and Jonji\u0107, N. (2014). Plasma levels of osteopontin and vascular endothelial growth factor in association with clinical features and parameters of tumor burden in patients with multiple myeloma. Biomed. Res. Int., 2014.","DOI":"10.1155\/2014\/513170"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"11763","DOI":"10.18632\/oncotarget.14343","article-title":"Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism","volume":"8","author":"Baek","year":"2016","journal-title":"Oncotarget"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/leu.2010.214","article-title":"The endosteal \u2018osteoblastic\u2019 niche and its role in hematopoietic stem cell homing and mobilization","volume":"24","author":"Helwani","year":"2010","journal-title":"Leukemia"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1182\/blood-2015-07-533588","article-title":"The hematopoietic stem cell niche in homeostasis and disease","volume":"126","author":"Calvi","year":"2015","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.stem.2014.06.008","article-title":"Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow","volume":"15","author":"Zhou","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature10783","article-title":"Endothelial and perivascular cells maintain haematopoietic stem cells","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.celrep.2019.06.031","article-title":"Mapping Distinct Bone Marrow Niche Populations and Their Differentiation Paths","volume":"28","author":"Wolock","year":"2019","journal-title":"Cell Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nm.3706","article-title":"Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells","volume":"20","author":"Zhao","year":"2014","journal-title":"Nat. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nm.3707","article-title":"Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion","volume":"20","author":"Bruns","year":"2014","journal-title":"Nat. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1182\/blood-2012-10-463414","article-title":"Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning","volume":"121","author":"Olson","year":"2013","journal-title":"Blood"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41467-017-02376-5","article-title":"Proliferation dynamics of acute myeloid leukaemia and haematopoietic progenitors competing for bone marrow space","volume":"9","author":"Akinduro","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1084\/jem.20140131","article-title":"Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs","volume":"211","author":"Boyd","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Ortiz, A., Rodr\u00edguez-Garc\u00eda, Y., Encinas, J., Maroto-Mart\u00edn, E., Castellano, E., Teixid\u00f3, J., and Mart\u00ednez-L\u00f3pez, J. (2021). The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression. Cancers, 13.","DOI":"10.3390\/cancers13020217"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/leu.2013.148","article-title":"Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib","volume":"27","author":"Stessman","year":"2013","journal-title":"Leukemia"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s12185-014-1583-1","article-title":"Regulation of hematopoiesis in endosteal microenvironments","volume":"99","author":"Asada","year":"2014","journal-title":"Int. J. Hematol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.beha.2013.10.004","article-title":"Osteolineage cells and regulation of the hematopoietic stem cell","volume":"26","author":"Calvi","year":"2013","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3324\/haematol.2018.197004","article-title":"Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesis","volume":"103","author":"Le","year":"2018","journal-title":"Haematologica"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature07639","article-title":"Detection of functional haematopoietic stem cell niche using real-time imaging","volume":"457","author":"Xie","year":"2008","journal-title":"Nature"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02040","article-title":"Osteoblastic cells regulate the haematopoietic stem cell niche","volume":"425","author":"Calvi","year":"2003","journal-title":"Nature"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nature02041","article-title":"Identification of the haematopoietic stem cell niche and control of the niche size","volume":"425","author":"Zhang","year":"2003","journal-title":"Nature"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/stem.160007","article-title":"The Role of Osteoblasts in the Hematopoietic Microenvironment","volume":"16","author":"Taichman","year":"1998","journal-title":"Stem Cells"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3324\/haematol.2009.018671","article-title":"Cathepsin X is secreted by human osteoblasts, digests CXCL-12 and impairs adhesion of hematopoietic stem and progenitor cells to osteoblasts","volume":"95","author":"Staudt","year":"2010","journal-title":"Haematologica"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1182\/blood-2003-11-4011","article-title":"Hematopoiesis is severely altered in mice with an induced osteoblast deficiency","volume":"103","author":"Visnjic","year":"2004","journal-title":"Blood"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1182\/blood-2006-08-041384","article-title":"Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells","volume":"109","author":"Zhu","year":"2007","journal-title":"Blood"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.stem.2007.06.001","article-title":"Lack of Evidence that Hematopoietic Stem Cells Depend on N-Cadherin-Mediated Adhesion to Osteoblasts for Their Maintenance","volume":"1","author":"Kiel","year":"2007","journal-title":"Cell Stem Cell"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.stem.2008.10.005","article-title":"Hematopoietic Stem Cells Do Not Depend on N-Cadherin to Regulate Their Maintenance","volume":"4","author":"Kiel","year":"2009","journal-title":"Cell Stem Cell"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1182\/blood.V118.21.2390.2390","article-title":"N-Cadherin in Osteolineage Cells Is Not Required for Maintenance of Hematopoietic Stem Cells","volume":"118","author":"Greenbaum","year":"2011","journal-title":"Blood"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2007.08.025","article-title":"Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment","volume":"131","author":"Sacchetti","year":"2007","journal-title":"Cell"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nyas.12578","article-title":"The osteoblastic niche in the context of multiple myeloma","volume":"1335","author":"Toscani","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Pennisi, A., Ling, W., Li, X., Khan, S., Wang, Y., Barlogie, B., Shaughnessy, J.D., and Yaccoby, S. (2010). Consequences of Daily Administered Parathyroid Hormone on Myeloma Growth, Bone Disease, and Molecular Profiling of Whole Myelomatous Bone. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015233"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood-2006-11-059188","article-title":"The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients","volume":"110","author":"Giuliani","year":"2007","journal-title":"Blood"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bone.2015.02.021","article-title":"Dynamic interplay between bone and multiple myeloma: Emerging roles of the osteoblast","volume":"75","author":"Reagan","year":"2015","journal-title":"Bone"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1182\/blood-2006-05-026112","article-title":"Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition","volume":"108","author":"Giuliani","year":"2006","journal-title":"Blood"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1182\/blood-2004-12-4986","article-title":"Myeloma cells block RUNX2\/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation","volume":"106","author":"Giuliani","year":"2005","journal-title":"Blood"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5312\/wjo.v4.i4.198","article-title":"Role of osteoclasts in regulating hematopoietic stem and progenitor cells","volume":"4","author":"Miyamoto","year":"2013","journal-title":"World J. Orthop."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/cr.2011.21","article-title":"Osteoclast activity modulates B-cell development in the bone marrow","volume":"21","author":"Mansour","year":"2011","journal-title":"Cell Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1084\/jem.20110994","article-title":"Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow","volume":"209","author":"Mansour","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1182\/blood.V95.11.3363","article-title":"Intramedullary and extramedullary B lymphopoiesis in osteopetrotic mice","volume":"95","author":"Tagaya","year":"2000","journal-title":"Blood"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Zeytin, I.C., Alkan, B., Ozdemir, C., Cetinkaya, D., and Okur, F.V. (2021). Modeling osteoclast defect and altered hematopoietic stem cell niche in osteopetrosis with patient-derived iPSCs. Res. Sq., 1.","DOI":"10.21203\/rs.3.rs-258821\/v1"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3389\/fimmu.2017.00954","article-title":"Emerging Roles of Osteoclasts in the Modulation of Bone Microenvironment and Immune Suppression in Multiple Myeloma","volume":"8","author":"Mansour","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.exphem.2004.03.015","article-title":"New insight in the mechanism of osteoclast activation and formation in multiple myeloma: Focus on the receptor activator of NF-kappaB ligand (RANKL)","volume":"32","author":"Giuliani","year":"2004","journal-title":"Exp. Hematol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1182\/blood-2002-09-2684","article-title":"RANK ligand and osteoprotegerin in myeloma bone disease","volume":"101","author":"Sezer","year":"2003","journal-title":"Blood"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1073\/pnas.201394498","article-title":"Multiple myeloma disrupts the TRANCE\/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression","volume":"98","author":"Pearse","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/leu.2008.174","article-title":"Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma","volume":"22","author":"Breitkreutz","year":"2008","journal-title":"Leukemia"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.leukres.2008.07.028","article-title":"Bortezomib inhibits maturation and function of osteoclasts from PBMCs of patients with multiple myeloma by downregulating TRAF6","volume":"33","author":"Hongming","year":"2009","journal-title":"Leuk. Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.immuni.2010.08.017","article-title":"The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche","volume":"33","author":"Omatsu","year":"2010","journal-title":"Immunity"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nyas.12384","article-title":"Regulation of hematopoiesis by activators and inhibitors of Wnt signaling from the niche","volume":"1310","author":"Schreck","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2013.10.002","article-title":"Regulation of hematopoietic stem cells by bone marrow stromal cells","volume":"35","author":"Anthony","year":"2014","journal-title":"Trends Immunol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.immuni.2004.05.001","article-title":"Cellular Niches Controlling B Lymphocyte Behavior within Bone Marrow during Development","volume":"20","author":"Tokoyoda","year":"2004","journal-title":"Immunity"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature11926","article-title":"CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance","volume":"495","author":"Greenbaum","year":"2013","journal-title":"Nature"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.immuni.2011.02.016","article-title":"Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity","volume":"34","author":"Shi","year":"2011","journal-title":"Immunity"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 Axis in Cancer: From Mechanisms to Clinical Applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","article-title":"A review on CXCR4\/CXCL12 axis in oncology: No place to hide","volume":"49","author":"Domanska","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature08099","article-title":"Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment","volume":"460","author":"Naveiras","year":"2009","journal-title":"Nature"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"101564","DOI":"10.1016\/j.beem.2021.101564","article-title":"Bone marrow adiposity and the hematopoietic niche: A historical perspective of reciprocity, heterogeneity, and lineage commitment","volume":"35","author":"Tratwal","year":"2021","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Cuminetti, V., and Arranz, L. (2019). Bone Marrow Adipocytes: The Enigmatic Components of the Hematopoietic Stem Cell Niche. J. Clin. Med., 8.","DOI":"10.3390\/jcm8050707"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1038\/s41375-020-0886-x","article-title":"Adipocytes in hematopoiesis and acute leukemia: Friends, enemies, or innocent bystanders?","volume":"34","author":"Zinngrebe","year":"2020","journal-title":"Leukemia"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/jcp.20655","article-title":"Human subcutaneous adipose cells support complete differentiation but not self-renewal of hematopoietic progenitors","volume":"208","author":"Corre","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bone.2018.01.020","article-title":"Characterization of the bone marrow adipocyte niche with three-dimensional electron microscopy","volume":"118","author":"Robles","year":"2018","journal-title":"Bone"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2141.2004.05198.x","article-title":"Human bone marrow adipocytes support complete myeloid and lymphoid differentiation from human CD34+ cells","volume":"127","author":"Corre","year":"2004","journal-title":"Br. J. Haematol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fendo.2016.00090","article-title":"Bone Marrow Adipose Tissue: A New Player in Cancer Metastasis to Bone","volume":"7","author":"Morris","year":"2016","journal-title":"Front. Endocrinol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41416-021-01371-4","article-title":"Myeloma-bone marrow adipocyte axis in tumour survival and treatment response","volume":"125","author":"Jafari","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.1002\/jcp.26884","article-title":"Adipokines, adiposity, and bone marrow adipocytes: Dangerous accomplices in multiple myeloma","volume":"233","author":"Morris","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2018.03.011","article-title":"Bone marrow adiposity and multiple myeloma","volume":"118","author":"Morris","year":"2019","journal-title":"Bone"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.leu.2404658","article-title":"Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells","volume":"21","author":"Caers","year":"2007","journal-title":"Leukemia"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cell.2005.10.041","article-title":"Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow","volume":"124","author":"Katayama","year":"2006","journal-title":"Cell"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.immuni.2018.03.024","article-title":"Niches for Hematopoietic Stem Cells and Their Progeny","volume":"48","author":"Wei","year":"2018","journal-title":"Immunity"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.immuni.2012.05.021","article-title":"Adrenergic nerves govern circadian leukocyte recruitment to tissues","volume":"37","author":"Scheiermann","year":"2012","journal-title":"Immunity"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"618843","DOI":"10.3389\/fimmu.2020.618843","article-title":"Circadian Control of Immunity","volume":"11","author":"Ikuta","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"221","DOI":"10.15698\/cst2019.07.192","article-title":"Stress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesis","volume":"3","author":"Hanns","year":"2019","journal-title":"Cell Stress Chaperones"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature13383","article-title":"Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms","volume":"512","author":"Arranz","year":"2014","journal-title":"Nature"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.stem.2014.06.020","article-title":"Acute Myelogenous Leukemia-Induced Sympathetic Neuropathy Promotes Malignancy in an Altered Hematopoietic Stem Cell Niche","volume":"15","author":"Hanoun","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajh.24582","article-title":"Beta-blockers improve survival outcomes in patients with multiple myeloma: A retrospective evaluation","volume":"92","author":"Hwa","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00432-012-1331-y","article-title":"New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma","volume":"139","author":"Kozanoglu","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"912060","DOI":"10.3389\/fonc.2022.912060","article-title":"Megakaryocytes as the Regulator of the Hematopoietic Vascular Niche","volume":"12","author":"Zhan","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.devcel.2018.01.016","article-title":"Lineage-Biased Hematopoietic Stem Cells Are Regulated by Distinct Niches","volume":"44","author":"Pinho","year":"2018","journal-title":"Dev. Cell"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1161\/ATVBAHA.119.312129","article-title":"New Insights Into the Differentiation of Megakaryocytes From Hematopoietic Progenitors","volume":"39","author":"Noetzli","year":"2019","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbrc.2014.10.095","article-title":"Megakaryocytes are essential for HSC quiescence through the production of thrombopoietin","volume":"454","author":"Takubo","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2016.12.021","article-title":"How do megakaryocytic microparticles target and deliver cargo to alter the fate of hematopoietic stem cells?","volume":"247","author":"Jiang","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/09537104.2013.805405","article-title":"Bone marrow megakaryocytes, soluble P-selectin and thrombopoietic cytokines in multiple myeloma patients","volume":"25","author":"Lemancewicz","year":"2014","journal-title":"Platelets"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Wong, D., Winter, O., Hartig, C., Siebels, S., Szyska, M., Tiburzy, B., Meng, L., Kulkarni, U., F\u00e4hnrich, A., and Bommert, K. (2014). Eosinophils and megakaryocytes support the early growth of murine MOPC315 myeloma cells in their bone marrow niches. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109018"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1158\/2767-9764.CRC-22-0368","article-title":"S100A8\/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes","volume":"3","author":"Lin","year":"2023","journal-title":"Cancer Res Commun."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1046\/j.1365-2141.1998.01101.x","article-title":"Interleukin-1 in multiple myeloma: Producer cells and their role in the control of IL-6 production","volume":"103","author":"Costes","year":"1998","journal-title":"Br. J. Haematol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1182\/blood-2009-11-253534","article-title":"Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs","volume":"116","author":"Winkler","year":"2010","journal-title":"Blood"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.exphem.2021.07.001","article-title":"Role of macrophages and phagocytes in orchestrating normal and pathologic hematopoietic niches","volume":"100","author":"Summers","year":"2021","journal-title":"Exp. Hematol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.stem.2016.01.013","article-title":"CD82\/KAI1 Maintains the Dormancy of Long-Term Hematopoietic Stem Cells through Interaction with DARC-Expressing Macrophages","volume":"18","author":"Hur","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Man, Y., Yao, X., Yang, T., and Wang, Y. (2021). Hematopoietic Stem Cell Niche During Homeostasis, Malignancy, and Bone Marrow Transplantation. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.621214"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.3057","article-title":"CD169+ macrophages provide a niche promoting erythropoiesis under homeostasis and stress","volume":"19","author":"Chow","year":"2013","journal-title":"Nat. Med."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/ni.2408","article-title":"Monocytes-macrophages that express \u03b1-smooth muscle actin preserve primitive hematopoietic cells in the bone marrow","volume":"13","author":"Ludin","year":"2012","journal-title":"Nat. Immunol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12185-014-1561-7","article-title":"Innate immune cells as homeostatic regulators of the hematopoietic niche","volume":"99","author":"Weiss","year":"2014","journal-title":"Int. J. Hematol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00277-012-1652-6","article-title":"Tumor-associated macrophages as a prognostic parameter in multiple myeloma","volume":"92","author":"Sucak","year":"2013","journal-title":"Ann. Hematol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"112685","DOI":"10.18632\/oncotarget.22340","article-title":"Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.7150\/jca.30102","article-title":"High numbers of CD163+ tumor-associated macrophages correlate with poor prognosis in multiple myeloma patients receiving bortezomib-based regimens","volume":"10","author":"Wang","year":"2019","journal-title":"J. Cancer"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/leu.2015.191","article-title":"Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma","volume":"30","author":"Panchabhai","year":"2015","journal-title":"Leukemia"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"11283","DOI":"10.18632\/oncotarget.2207","article-title":"Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4\/CXCL12 axis and promote their polarization toward the M2 phenotype","volume":"5","author":"Beider","year":"2014","journal-title":"Oncotarget."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"e003975","DOI":"10.1136\/jitc-2021-003975","article-title":"Tumor-associated macrophages in multiple myeloma: Advances in biology and therapy","volume":"10","author":"Sun","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10555-020-09943-1","article-title":"Macrophages in multiple myeloma: Key roles and therapeutic strategies","volume":"40","author":"Opperman","year":"2021","journal-title":"Cancer Metastasis Rev."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s12253-015-9921-z","article-title":"Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma","volume":"21","author":"Alexandrakis","year":"2015","journal-title":"Pathol. Oncol. Res."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"183602","DOI":"10.1155\/2013\/183602","article-title":"Multiple myeloma macrophages: Pivotal players in the tumor microenvironment","volume":"2013","author":"Berardi","year":"2013","journal-title":"J. Oncol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"106709","DOI":"10.1016\/j.leukres.2021.106709","article-title":"Tumor-associated macrophages modulate angiogenesis and tumor growth in a xenograft mouse model of multiple myeloma","volume":"110","author":"Sun","year":"2021","journal-title":"Leuk. Res."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.3390\/curroncol30070455","article-title":"Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications","volume":"30","author":"Cencini","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2057837","DOI":"10.1080\/2162402X.2022.2057837","article-title":"Myeloma-derived IL-32\u03b3 induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis","volume":"11","author":"Liu","year":"2022","journal-title":"OncoImmunology"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Cencini, E., Fabbri, A., Sicuranza, A., Gozzetti, A., and Bocchia, M. (2021). The Role of Tumor-Associated Macrophages in Hematologic Malignancies. Cancers, 13.","DOI":"10.3390\/cancers13143597"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2141.2012.09154.x","article-title":"Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells","volume":"158","author":"Kim","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1182\/blood-2002-08-2383","article-title":"Macrophage inflammatory protein 1-alpha (MIP-1\u03b1) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells","volume":"101","author":"Lentzsch","year":"2003","journal-title":"Blood"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-540-85772-3_4","article-title":"Angiogenesis and vasculogenesis in multiple myeloma: Role of inflammatory cells","volume":"183","author":"Vacca","year":"2011","journal-title":"Recent Results Cancer Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.immuni.2018.01.006","article-title":"Interleukin-10 Directly Inhibits CD8+ T Cell Function by Enhancing N-Glycan Branching to Decrease Antigen Sensitivity","volume":"48","author":"Smith","year":"2018","journal-title":"Immunity"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2019.01.012","article-title":"Multiple myeloma cell-derived IL-32\u03b3 increases the immunosuppressive function of macrophages by promoting indoleamine 2,3-dioxygenase (IDO) expression","volume":"446","author":"Yan","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1182\/blood-2018-10-844571","article-title":"Neutrophils as regulators of the hematopoietic niche","volume":"133","author":"Lucas","year":"2019","journal-title":"Blood"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nm.4448","article-title":"Granulocyte-derived TNF\u03b1 promotes vascular and hematopoietic regeneration in the bone marrow","volume":"24","author":"Bowers","year":"2018","journal-title":"Nat. Med."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.cell.2013.04.040","article-title":"Rhythmic modulation of the hematopoietic niche through neutrophil clearance","volume":"153","author":"Pitaval","year":"2013","journal-title":"Cell"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2005.01.011","article-title":"Phagocytosis of Apoptotic Neutrophils Regulates Granulopoiesis via IL-23 and IL-17","volume":"22","author":"Stark","year":"2005","journal-title":"Immunity"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2015.10.040","article-title":"Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy","volume":"371","author":"Ramachandran","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/s41598-020-58859-x","article-title":"High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling","volume":"10","author":"Romano","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"6344344","DOI":"10.1155\/2021\/6344344","article-title":"Bone Marrow Neutrophils of Multiple Myeloma Patients Exhibit Myeloid-Derived Suppressor Cell Activity","volume":"2021","author":"Petersson","year":"2021","journal-title":"J. Immunol. Res."},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Botta, C., Mendicino, F., Martino, E.A., Vigna, E., Ronchetti, D., Correale, P., Morabito, F., Neri, A., and Gentile, M. (2021). Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities. Cancers, 13.","DOI":"10.3390\/cancers13133213"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.3390\/curroncol29110705","article-title":"Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment","volume":"29","author":"Ho","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_220","first-page":"6229","article-title":"T cell regulation of hematopoiesis","volume":"13","author":"Alexander","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1049301","DOI":"10.3389\/fimmu.2022.1049301","article-title":"Regulation of hematopoietic and leukemia stem cells by regulatory T cells","volume":"13","author":"Riether","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fimmu.2016.00184","article-title":"A T Cell View of the Bone Marrow","volume":"7","author":"Bonomo","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2004-07-2856","article-title":"Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells","volume":"105","author":"Monteiro","year":"2005","journal-title":"Blood"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jlb.64.5.657","article-title":"The role of IL-5 in bleomycin-induced pulmonary fibrosis","volume":"64","author":"McGarry","year":"1998","journal-title":"J. Leukoc. Biol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fphys.2019.01514","article-title":"Interleukin-5 in the Pathophysiology of Severe Asthma","volume":"10","author":"Pelaia","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/prd.12083","article-title":"Basic biology and role of interleukin-17 in immunity and inflammation","volume":"69","author":"Zenobia","year":"2015","journal-title":"Periodontology 2000"},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Lopes, R., Caetano, J., Ferreira, B., Barahona, F., Carneiro, E.A., and Jo\u00e3o, C. (2021). The Immune Microenvironment in Multiple Myeloma: Friend or Foe?. Cancers, 13.","DOI":"10.3390\/cancers13040625"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1038\/bcj.2013.34","article-title":"Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg\/Th17 balance","volume":"3","author":"Bryant","year":"2013","journal-title":"Blood Cancer J."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/10428199809059231","article-title":"The Expression of T Cell Related Costimulatory Molecules in Multiple Myeloma","volume":"31","author":"Brown","year":"1998","journal-title":"Leuk. Lymphoma"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13045-016-0345-3","article-title":"T cells in multiple myeloma display features of exhaustion and senescence at the tumor site","volume":"9","author":"Thangavadivel","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Lagreca, I., Riva, G., Nasillo, V., Barozzi, P., Castelli, I., Basso, S., Bettelli, F., Giusti, D., Cuoghi, A., and Bresciani, P. (2022). The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23095242"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/jlb.66.6.981","article-title":"Transforming growth factor \u03b2 from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes","volume":"66","author":"Cook","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.4161\/onci.22032","article-title":"Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma","volume":"1","author":"Brown","year":"2012","journal-title":"OncoImmunology"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"620596","DOI":"10.3389\/fimmu.2021.620596","article-title":"Treg and Oligoclonal Expansion of Terminal Effector CD8+ T Cell as Key Players in Multiple Myeloma","volume":"12","author":"Joshua","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2781","article-title":"Gammadelta T cell effector functions: A blend of innate programming and acquired plasticity","volume":"10","author":"Bonneville","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41590-022-01172-8","article-title":"B cells regulate hematopoietic stem cells via cholinergic signaling","volume":"23","author":"Patel","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"e20221221","DOI":"10.1084\/jem.20221221","article-title":"Myeloid-like B cells boost emergency myelopoiesis through IL-10 production during infection","volume":"220","author":"Kanayama","year":"2023","journal-title":"J. Exp. Med."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3389\/fimmu.2019.01183","article-title":"Bone Marrow Plasma Cells Modulate Local Myeloid-Lineage Differentiation via IL-10","volume":"10","author":"Meng","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"E3954","DOI":"10.1073\/pnas.1616417114","article-title":"Pre\/pro-B cells generate macrophage populations during homeostasis and inflammation","volume":"114","author":"Audzevich","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0268-960X(10)70003-5","article-title":"Multiple myeloma: Biology of the disease","volume":"24","author":"Mahindra","year":"2010","journal-title":"Blood Rev."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1182\/blood.V82.12.3712.3712","article-title":"Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion","volume":"82","author":"Uchiyama","year":"1993","journal-title":"Blood"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood.V87.3.1104.bloodjournal8731104","article-title":"Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B","volume":"87","author":"Chauhan","year":"1996","journal-title":"Blood"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.coi.2004.02.001","article-title":"Plasma cell differentiation and multiple myeloma","volume":"16","author":"Calame","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1182\/blood.V66.2.416.416","article-title":"Pre-B cells in peripheral blood of multiple myeloma patients","volume":"66","author":"Pilarski","year":"1985","journal-title":"Blood"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/10428199609054775","article-title":"Circulating Clonotypic B Cells in the Biology of Multiple Myeloma: Speculations on the Origin of Myeloma","volume":"22","author":"Pilarski","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.leukres.2003.09.015","article-title":"Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients","volume":"28","author":"Santonocito","year":"2004","journal-title":"Leuk. Res."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1038\/leu.2008.263","article-title":"A role for IFN-\u03bb1 in multiple myeloma B cell growth","volume":"22","author":"Novak","year":"2008","journal-title":"Leukemia"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1158\/1078-0432.CCR-12-0531","article-title":"Stemness of B-cell Progenitors in Multiple Myeloma Bone Marrow","volume":"18","author":"Boucher","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_249","first-page":"1285","article-title":"Assessment of the role of clonogenic B lymphocytes in the pathogenesis of multiple myeloma","volume":"8","author":"Sahota","year":"1994","journal-title":"Leukemia"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1182\/blood.V80.3.670.670","article-title":"Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo","volume":"80","author":"Murphy","year":"1992","journal-title":"Blood"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/meth.1996.0039","article-title":"NK Cells in the Regulation of Hematopoiesis","volume":"9","author":"Murphy","year":"1996","journal-title":"Methods"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12032-007-0007-y","article-title":"Clinical stage-depending decrease of NK cell activity in multiple myeloma patients","volume":"24","author":"Jurisic","year":"2007","journal-title":"Med. Oncol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF02827242","article-title":"IgG M-components in active myeloma patients induce a down-regulation of natural killer cell activity","volume":"27","author":"Frassanito","year":"1997","journal-title":"Int. J. Clin. Lab. Res."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2141.1996.4651006.x","article-title":"Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications","volume":"93","author":"Moro","year":"1996","journal-title":"Br. J. Haematol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1080\/10428190500472503","article-title":"Immune parameters in multiple myeloma patients: Influence of treatment and correlation with opportunistic infections","volume":"47","author":"Brandhorst","year":"2006","journal-title":"Leuk. Lymphoma"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3109\/10428194.2012.676175","article-title":"The role of natural killer cells in immunity against multiple myeloma","volume":"53","author":"Godfrey","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"ref_257","first-page":"17","article-title":"IgA monoclonal and polyclonal proteins as regulatory factors of the NK cytotoxic activity","volume":"50","author":"Galatiuc","year":"2001","journal-title":"Rom. J. Virol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1158\/0008-5472.CAN-15-1320","article-title":"Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment","volume":"75","author":"Ponzetta","year":"2015","journal-title":"Cancer Res."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ni1571","article-title":"Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches","volume":"9","author":"Sapoznikov","year":"2008","journal-title":"Nat. Immunol."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ni1249","article-title":"Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells","volume":"6","author":"Cavanagh","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1084\/jem.20101700","article-title":"Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice","volume":"208","author":"Christopher","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1172\/JCI78083","article-title":"Checkpoints that control B cell development","volume":"125","author":"Melchers","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1172\/JCI81919","article-title":"Stress-associated erythropoiesis initiation is regulated by type 1 conventional dendritic cells","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2009.08.019","article-title":"Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: A therapeutic target","volume":"16","author":"Chauhan","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1084\/jem.20052136","article-title":"Enhancement of clonogenicity of human multiple myeloma by dendritic cells","volume":"203","author":"Kukreja","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2249.2006.03037.x","article-title":"Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma","volume":"144","author":"Brimnes","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/leu.2015.11","article-title":"Targeting PD1\u2013PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells","volume":"29","author":"Ray","year":"2015","journal-title":"Leukemia"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/blood.V98.10.2992","article-title":"Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10","volume":"98","author":"Brown","year":"2001","journal-title":"Blood"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1182\/blood.V100.1.230","article-title":"Dendritic cells are functionally defective in multiple myeloma: The role of interleukin-6","volume":"100","author":"Ratta","year":"2002","journal-title":"Blood"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1634\/theoncologist.2010-0327","article-title":"Dendritic cells and malignant plasma cells: An alliance in multiple myeloma tumor progression?","volume":"16","author":"Tucci","year":"2011","journal-title":"Oncologist"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"100986","DOI":"10.1016\/j.blre.2022.100986","article-title":"Game of clones: Diverse implications for clonal hematopoiesis in lymphoma and multiple myeloma","volume":"56","author":"Meier","year":"2022","journal-title":"Blood Rev."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.seminoncol.2022.11.001","article-title":"Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias","volume":"49","author":"Testa","year":"2022","journal-title":"Semin. Oncol."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.seminoncol.2022.01.009","article-title":"The emerging importance and evolving understanding of clonal hematopoiesis in multiple myeloma","volume":"49","author":"DeStefano","year":"2022","journal-title":"Semin. Oncol."},{"key":"ref_274","doi-asserted-by":"crossref","unstructured":"Bou Zerdan, M., Nasr, L., Saba, L., Meouchy, P., Safi, N., Allam, S., Bhandari, J., and Chaulagain, C.P. (2022). A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology. Cancers, 14.","DOI":"10.3390\/cancers14153663"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1182\/blood-2022-169263","article-title":"Clonal Hematopoiesis: Exploiting Molecular Landscape of Multiple Myeloma Patients for Choosing the Most Appropriate Therapeutic Strategy","volume":"140","author":"Gelli","year":"2022","journal-title":"Blood"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1038\/s41467-020-16805-5","article-title":"Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant","volume":"11","author":"Mouhieddine","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_277","first-page":"317","article-title":"Clonal Hematopoiesis of Indeterminate Potential","volume":"113","author":"Heuser","year":"2016","journal-title":"Dtsch. \u00c4rzteblatt Int."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41698-017-0031-0","article-title":"Immune cell profiling in cancer: Molecular approaches to cell-specific identification","volume":"1","author":"Lyons","year":"2017","journal-title":"Npj Precis. Oncol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41591-018-0269-2","article-title":"Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma","volume":"24","author":"Ledergor","year":"2018","journal-title":"Nat. Med."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood.2018880930","article-title":"A niche-dependent myeloid transcriptome signature defines dormant myeloma cells","volume":"134","author":"Khoo","year":"2019","journal-title":"Blood"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s43018-020-0053-3","article-title":"Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma","volume":"1","author":"Zavidij","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_282","first-page":"282","article-title":"Co-evolution of tumor and immune cells during progression of multiple myeloma","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1158\/2767-9764.CRC-22-0022","article-title":"Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis","volume":"2","author":"Yao","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"ref_284","doi-asserted-by":"crossref","unstructured":"Chen, M., Wan, Y., Li, X., Xiang, J., Chen, X., Jiang, J., Han, X., Zhong, L., Xiao, F., and Liu, J. (2023). Dynamic single-cell RNA-seq analysis reveals distinct tumor program associated with microenvironmental remodeling and drug sensitivity in multiple myeloma. Cell Biosci., 13.","DOI":"10.1186\/s13578-023-00971-2"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bjh.18708","article-title":"Single-cell atlas of the immune microenvironment reveals macrophage reprogramming and the potential dual macrophage-targeted strategy in multiple myeloma","volume":"201","author":"Li","year":"2023","journal-title":"Br. J. Haematol."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1111\/cas.15800","article-title":"Distinct mechanisms of dysfunctional antigen-presenting DCs and monocytes by single-cell sequencing in multiple myeloma","volume":"114","author":"Jiang","year":"2023","journal-title":"Cancer Sci."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2141.1999.01337.x","article-title":"A history of haemopoietic cell transplantation","volume":"105","year":"1999","journal-title":"Br. J. Haematol."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"105326","DOI":"10.1016\/j.isci.2022.105326","article-title":"Immunotherapy approaches for hematological cancers","volume":"25","author":"Lanier","year":"2022","journal-title":"iScience"},{"key":"ref_289","doi-asserted-by":"crossref","unstructured":"Holthof, L.C., and Mutis, T. (2020). Challenges for Immunotherapy in Multiple Myeloma: Bone Marrow Microenvironment-Mediated Immune Suppression and Immune Resistance. Cancers, 12.","DOI":"10.3390\/cancers12040988"},{"key":"ref_290","first-page":"m3176","article-title":"Emerging immunotherapies in multiple myeloma","volume":"370","author":"Mailankody","year":"2020","journal-title":"BMJ"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"101929","DOI":"10.1016\/j.ctrv.2019.101929","article-title":"Multiple myeloma: Role of autologous transplantation","volume":"82","author":"Gavriatopoulou","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1097\/HS9.0000000000000163","article-title":"Insights on Multiple Myeloma Treatment Strategies","volume":"3","author":"Mateos","year":"2019","journal-title":"HemaSphere"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10555-017-9707-8","article-title":"The proteasome and proteasome inhibitors in multiple myeloma","volume":"36","author":"Gandolfi","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"ref_294","doi-asserted-by":"crossref","unstructured":"Palma, B.D., Marchica, V., Catarozzo, M.T., Giuliani, N., and Accardi, F. (2020). Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma. J. Clin. Med., 9.","DOI":"10.3390\/jcm9093022"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1182\/blood-2017-04-778423","article-title":"SLAMF7-CAR T cells eliminate myeloma and confer selective fratricide of SLAMF7+ normal lymphocytes","volume":"130","author":"Gogishvili","year":"2017","journal-title":"Blood"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"6084012","DOI":"10.1155\/2019\/6084012","article-title":"Monoclonal Antibody Therapies in Multiple Myeloma: A Challenge to Develop Novel Targets","volume":"2019","author":"Nishida","year":"2019","journal-title":"J. Oncol."},{"key":"ref_297","first-page":"e15440","article-title":"Role of Daratumumab in Combination With Standard Therapies in Patients With Relapsed and Refractory Multiple Myeloma","volume":"13","author":"Bapatla","year":"2021","journal-title":"Cureus"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.2147\/OTT.S174640","article-title":"Update on elotuzumab for the treatment of relapsed\/refractory multiple myeloma: Patients\u2019 selection and perspective","volume":"12","author":"Trudel","year":"2019","journal-title":"OncoTargets Ther."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1182\/blood-2021-151210","article-title":"Role of Daratumumab in Relapsed and Refractory Multiple Myeloma Patients: Meta-Analysis and Literature Review","volume":"138","author":"Abodunrin","year":"2021","journal-title":"Blood"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14712598.2022.2145882","article-title":"Elotuzumab in multiple myeloma","volume":"23","author":"Bruzzese","year":"2022","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2217\/fon-2020-1088","article-title":"Elotuzumab in the treatment of relapsed and refractory multiple myeloma","volume":"17","author":"Grosicki","year":"2021","journal-title":"Futur. Oncol."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1158\/1078-0432.CCR-12-2422","article-title":"B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma","volume":"19","author":"Carpenter","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1182\/blood-2016-04-711903","article-title":"T cells expressing an anti\u2013B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma","volume":"128","author":"Ali","year":"2016","journal-title":"Blood"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"8007","DOI":"10.1200\/JCO.2018.36.15_suppl.8007","article-title":"bb2121 anti-BCMA CAR T-cell therapy in patients with relapsed\/refractory multiple myeloma: Updated results from a multicenter phase I study","volume":"36","author":"Raje","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13045-018-0681-6","article-title":"A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma","volume":"11","author":"Zhao","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41434-021-00254-w","article-title":"CARAMBA: A first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma","volume":"28","author":"Prommersberger","year":"2021","journal-title":"Gene Ther."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/leu.2013.279","article-title":"CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma","volume":"28","author":"Chu","year":"2013","journal-title":"Leukemia"},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"e1030","DOI":"10.1002\/imed.1030","article-title":"Non-BCMA targeted CAR-T cell therapies for multiple myeloma","volume":"1","author":"Wang","year":"2021","journal-title":"ImmunoMedicine"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/s41375-020-0930-x","article-title":"Development of CAR-T cell therapies for multiple myeloma","volume":"34","author":"Gagelmann","year":"2020","journal-title":"Leukemia"},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/s41591-023-02589-w","article-title":"Elranatamab in relapsed or refractory multiple myeloma: The MagnetisMM-1 phase 1 trial","volume":"29","author":"Bahlis","year":"2023","journal-title":"Nat. Med."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fimmu.2020.00501","article-title":"Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions","volume":"11","author":"Caraccio","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_312","unstructured":"(2023, September 23). CTG Labs\u2014NCBI, Available online: https:\/\/clinicaltrials.gov\/search?cond=multiple%20myeloma&viewType=Table&limit=50&aggFilters=phase:1%202%203%204,results:with,status:com%20act%20not%20rec&intr=Immunotherapy."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/11\/1629\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:18:56Z","timestamp":1760131136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/11\/1629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":312,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["biom13111629"],"URL":"https:\/\/doi.org\/10.3390\/biom13111629","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]}}}